載入...
A Recombinant Influenza A/H1N1 Carrying A Short Immunogenic Peptide of MERS-CoV as Bivalent Vaccine in BALB/c Mice
Middle East Respiratory Syndrome Coronavirus (MERS-CoV) became a global human health threat since its first documentation in humans in 2012. An efficient vaccine for the prophylaxis of humans in hotspots of the infection (e.g., Saudi Arabia) is necessary but no commercial vaccines are yet approved....
Na minha lista:
| 發表在: | Pathogens |
|---|---|
| Main Authors: | , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
MDPI
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6963271/ https://ncbi.nlm.nih.gov/pubmed/31810359 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pathogens8040281 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|